By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Clearside Biomedical 

1220 Old Alpharetta Road
Suite 300
Alpharetta   Georgia  30005  U.S.A.
Phone: 678-270-3631 Fax:



Company News
Clearside Biomedical Announces Fifth Patent Issued In The U.S. Related To Proprietary Microneedle Drug Delivery Methods And Devices 11/12/2015 12:11:24 PM
Clearside Biomedical Completes Enrollment In Phase 2 Clinical Trial Of CLS-TA Using Suprachoroidal Space (SCS) Drug Administration 10/12/2015 10:34:58 AM
Clearside Biomedical Announces 50th Patient Enrolled Using Suprachoroidal Drug Administration 9/24/2015 10:22:18 AM
Clearside Biomedical To Present At The 13th Congress Of International Ocular Inflammation Society (IOIS) In San Francisco, CA 9/22/2015 10:51:57 AM
Clearside Biomedical To Present At International Symposium On Ocular Pharmacology And Therapeutics (ISOPT) Clinical Meeting 7/9/2015 8:13:24 AM
Clearside Biomedical Announces Favorable End-of-Phase 2 Review With The FDA 6/16/2015 11:30:49 AM
Clearside Biomedical And Santen, Inc. Announce Research Collaboration In Glaucoma 5/4/2015 8:22:42 AM
Clearside Biomedical To Report Efficacy And Safety Results In Non-Infectious Uveitis Using A Single Suprachoroidal Injection Of Triamcinolone Acetonide At 2015 ARVO Meeting 4/30/2015 1:25:53 PM
Spark Therapeutics (ONCE) And Clearside Biomedical Announce Exclusive Option To License Technology For Potentially Differentiated Delivery Of Gene Therapy To The Eye 4/29/2015 6:55:09 AM
Clearside Biomedical Announces Purchase Of Iscience Patent Portfolio For Suprachoroidal Space Drug Delivery 4/22/2015 10:41:46 AM